High-Level S100A6 Promotes Metastasis and Predicts the Outcome of T1–T2 Stage in Clear Cell Renal Cell Carcinoma
详细信息 查看全文
- 作者：Xiangjun Lyu ; Hongzhao Li ; Xin Ma ; Xintao Li ; Yu Gao…
- 关键词：S100A6 ; Clear cell renal cell carcinoma ; Migration ; Invasion ; Prognosis
- 刊名：Cell Biochemistry and Biophysics
- 出版年：2015
- 出版时间：January 2015
- 年：2015
- 卷：71
- 期：1
- 页码：279-290
- 全文大小：9,103 KB
- 参考文献：1. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011). Global cancer statistics. / CA: Cancer Journal for Clinicians, / 61, 69-0.
2. Gupta, K., Miller, J. D., Li, J. Z., Russell, M. W., & Charbonneau, C. (2008). Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review. / Cancer Treatment Reviews, / 34, 193-05. CrossRef
3. Motzer, R. J., Bacik, J., Schwartz, L. H., Reuter, V., Russo, P., et al. (2004). Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. / Journal of Clinical Oncology, / 22, 454-63. CrossRef
4. Sastry, M., Ketchem, R. R., Crescenzi, O., Weber, C., Lubienski, M. J., et al. (1998). The three-dimensional structure of Ca(2+)-bound calcyclin: Implications for Ca(2+)-signal transduction by S100 proteins. / Structure, / 6, 223-31. CrossRef
5. Calabretta, B., Battini, R., Kaczmarek, L., de Riel, J. K., & Baserga, R. (1986). Molecular cloning of the cDNA for a growth factor-inducible gene with strong homology to S-100, a calcium-binding protein. / Journal of Biological Chemistry, / 261, 12628-2632.
6. Courtois-Coutry, N., Le, M. C., Boulkroun, S., Fay, M., Cluzeaud, F., et al. (2002). Calcyclin is an early vasopressin-induced gene in the renal collecting duct. Role in the long term regulation of ion transport. / Journal of Biological Chemistry, / 277, 25728-5734. CrossRef
7. Breen, E. C., & Tang, K. (2003). Calcyclin (S100A6) regulates pulmonary fibroblast proliferation, morphology, and cytoskeletal organization in?vitro. / Journal of Cellular Biochemistry, / 88, 848-54. CrossRef
8. Weterman, M. A., Stoopen, G. M., van Muijen, G. N., Kuznicki, J., Ruiter, D. J., & Bloemers, H. P. (1992). Expression of calcyclin in human melanoma cell lines correlates with metastatic behavior in nude mice. / Cancer Research, / 52, 1291-296.
9. Komatsu, K., Murata, K., Kameyama, M., Ayaki, M., Mukai, M., et al. (2002). Expression of S100A6 and S100A4 in matched samples of human colorectal mucosa, primary colorectal adenocarcinomas and liver metastases. / Oncology (Williston Park), / 63, 192-00. CrossRef
10. Komatsu, K., Andoh, A., Ishiguro, S., Suzuki, N., Hunai, H., et al. (2000). Increased expression of S100A6 (calcyclin), a calcium-binding protein of the S100 family, in human colorectal adenocarcinomas. / Clinical Cancer Research, / 6, 172-77.
11. Komatsu, K., Kobune-Fujiwara, Y., Andoh, A., Ishiguro, S., Hunai, H., et al. (2000). Increased expression of S100A6 at the invading fronts of the primary lesion and liver metastasis in patients with colorectal adenocarcinoma. / British Journal of Cancer, / 83, 769-74. CrossRef
12. Yang, Y. Q., Zhang, L. J., Dong, H., Jiang, C. L., Zhu, Z. G., et al. (2007). Upregulated expression of S100A6 in human gastric cancer. / Journal of Digestive Diseases, / 8, 186-93. CrossRef
13. Vimalachandran, D., Greenhalf, W., Thompson, C., Luttges, J., Prime, W., et al. (2005). High nuclear S100A6 (calcyclin) is significantly associated with poor survival in pancreatic cancer patients. / Cancer Research, / 65, 3218-225.
14. Shekouh, A. R., Thompson, C. C., Prime, W., Campbell, F., Hamlett, J., et al. (2003). Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma. / Proteomics, / 3, 1988-001. CrossRef
15. Camby, I., Nagy, N., Lopes, M. B., Schafer, B. W., Maurage, C. A., et al. (1999). Supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas are characterized by a differential expression of S100 proteins. / Brain Pathology (Zurich, Switzerland), / 9, 1-9.
文摘
S100A6 (calcyclin), functions in cell cycle progression and differentiation, has been reported to promote the tumorigenesis and malignancy of many types of cancers. Clear cell renal cell carcinoma (ccRCC) is the most common subtype of RCC, lacking both promising prognostic markers and effective therapeutic targets. In our previous study, we have found the elevated S100A6 in the ccRCC tumor tissues, and the differentially expressed genes determined by microarray analysis were found to be strongly related to tumor metastasis after S100A6 knockdown and overexpression in the ccRCC cell line 786-O. The mRNA expression of S100A6 detected by RT-PCR in 6 cell lines and 174 tumor tissues, including 58 metastatic ccRCC and 116 clinicopathological features paired non-metastatic ccRCC (1:2), indicated S100A6 was elevated in the metastatic cells and tumor tissues. The protein expression was consistent with mRNA expression. The biological function of S100A6 in promoting metastasis was determined through overexpression and knockdown of S100A6 in the ccRCC cell lines 786-O, caki-1, and ACHN. In the scratch wound migration assay as well as migration and invasion assays, S100A6 knockdown significantly suppressed the migratory and invasive abilities of tumor cells, whereas overexpression enhanced the malignancy. Further research with the follow-up data of 129 ccRCC patients were analyzed by the Cox regression and survival analysis. The expression of S100A6 was up-regulated in metastatic ccRCC cells. In the metastatic tumor tissues, the expression of S100A6 was also higher than in the non-metastatic tissues. High S100A6 expression might be crucial to promote metastasis in ccRCC by enhancing the ability of tumor cells migration and invasion. In addition, the quantitative mRNA expression of S100A6 in the tumor tissues was an independent risk factor and might be used as a prognostic marker for the metastatic risk of the localized T1–T2 stage ccRCC.